Gemfibrozil

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2315 publications

Ni-Catalyzed Asymmetric Reductive Arylation and Alkenylation of N-Sulfonyl Imines.

Ni-Catalyzed Asymmetric Reductive Arylation and Alkenylation of N-Sulfonyl Imines.

Journal: Organic letters

Published: January 02, 2026

Drug Development.

Drug Development.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 26, 2025

Estimating the impact of patient-level risk factors and time-varying hospital unit on healthcare-associated Clostridioides difficile infection using cross-classified multilevel models.

Estimating the impact of patient-level risk factors and time-varying hospital unit on healthcare-associated Clostridioides difficile infection using cross-classified multilevel models.

Journal: Infection control and hospital epidemiology

Published: December 01, 2025

Combined impacts of a lipid lowering drug, gemfibrozil, and temperature on bioenergetics and digestive gland function of a marine bivalve Mytilus edulis.

Combined impacts of a lipid lowering drug, gemfibrozil, and temperature on bioenergetics and digestive gland function of a marine bivalve Mytilus edulis.

Journal: Aquatic toxicology (Amsterdam, Netherlands)

Published: October 13, 2025

Not all fibrates are made equal: Learning from biology and clinical trials.

Not all fibrates are made equal: Learning from biology and clinical trials.

Journal: Atherosclerosis

Published: September 18, 2025

Degradation of Typical PPCPs During Anaerobic Digestion and in Soil.

Degradation of Typical PPCPs During Anaerobic Digestion and in Soil.

Journal: Toxics

Published: August 18, 2025

Bezafibrate, a Pan PPAR agonist, attenuates experimental rheumatoid arthritis via PPAR dependent modulation of inflammatory pathways with emphasis on PPAR γ activity.

Bezafibrate, a Pan PPAR agonist, attenuates experimental rheumatoid arthritis via PPAR dependent modulation of inflammatory pathways with emphasis on PPAR γ activity.

Journal: International immunopharmacology

Published: August 06, 2025

Can fibrate therapy redefine the management of diabetic retinopathy? A comprehensive systematic review and meta-analysis of efficacy and safety.

Can fibrate therapy redefine the management of diabetic retinopathy? A comprehensive systematic review and meta-analysis of efficacy and safety.

Journal: Journal of diabetes and its complications

Published: August 04, 2025

Activation of PPARα by gemfibrozil lowers tau-associated neuropathology in the MAPT mouse model of Alzheimer's disease.

Activation of PPARα by gemfibrozil lowers tau-associated neuropathology in the MAPT mouse model of Alzheimer's disease.

Journal: Brain research

Published: July 28, 2025

Unraveling the Function of PPARα in Neurodegenerative Disorders: A Potential Pathway to Novel Therapies.

Unraveling the Function of PPARα in Neurodegenerative Disorders: A Potential Pathway to Novel Therapies.

Journal: Biomedicines

Published: July 17, 2025

IN VITRO ASSESSMENT OF REVERSIBLE AND METABOLISM-DEPENDENT INHIBITORY EFFECTS OF PROPOXAZEPAM ON CYP2C8 ACTIVITY.

IN VITRO ASSESSMENT OF REVERSIBLE AND METABOLISM-DEPENDENT INHIBITORY EFFECTS OF PROPOXAZEPAM ON CYP2C8 ACTIVITY.

Journal: Experimental oncology

Published: July 10, 2025

IN VITRO ASSESSMENT OF REVERSIBLE AND METABOLISM-DEPENDENT INHIBITORY EFFECTS OF PROPOXAZEPAM ON CYP2C8 ACTIVITY.

IN VITRO ASSESSMENT OF REVERSIBLE AND METABOLISM-DEPENDENT INHIBITORY EFFECTS OF PROPOXAZEPAM ON CYP2C8 ACTIVITY.

Journal: Experimental oncology

Published: July 10, 2025

Showing 1-12 of 2,315

Last Updated: 02/24/2026